Ally Bridge Group

Funding rounds backed by Ally Bridge Group.

Export CSV
Funding disclosed in full
$455M
Median round
$100M
Rounds in calculation
3
3 rounds
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
AdvanCell

Develops lead-212 targeted alpha therapies to treat cancer

$315MSeries DBiotechAustralia
19 participantsAbingworthAlly Bridge GroupAlpha WaveBain Capital Life SciencesBrandon CapitalCatalio Capital ManagementEli Lilly and CompanyEventide Asset ManagementFidelity Management & Research CompanyMorningsidePiper HeartlandProto AxiomSanofi VenturesSV Health InvestorsSymBiosisTenmileTime BioVenturesT. Rowe Price AssociatesVelosity Capital
Calyxo

Develops medical devices for kidney stone treatment and removal

$40MSeries FHealthtechUnited States
5 participantsAlly Bridge GroupAvidity PartnersCRGJanus Henderson InvestorsQuesta Capital
Imperative Care

Develops treatments for patients suffering from thromboembolic disease

$100MGrowthHealthtechUnited States
7 participantsAlly Bridge GroupBain Capital Life SciencesBrown AdvisoryCatalio Capital ManagementElevage Medical TechnologiesLongaeva PartnersPerceptive Advisors